Analysis of Insertions and Deletions in the gag p6 Region of Diverse HIV Type 1 Strains
- 1 October 2004
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 20 (10) , 1119-1125
- https://doi.org/10.1089/aid.2004.20.1119
Abstract
Sequence variation in the gag p6 region in subtype B HIV-1 has been associated with changes in viral replication capacity and antiretroviral drug susceptibility. We examined sequence variation in the HIV-1 gag p6 region using plasma samples from 22 individuals with non-subtype B HIV-1 infection [subtypes A, C, D, F, and G, and circulating recombinant forms (CRFs) CRF01-AE and CRF02_AG]. An additional 105 gag sequences from the Los Alamos National Laboratory database were also analyzed. Extensive length variation was observed in the p6 gag region. Specific patterns of insertions and deletions were observed in different subtypes and CRFs, and no two subtypes or CRFs had the same general pattern. PTAP duplications were more common in subtype C than other strains (3 of 14 in subtype C vs. 2 of 113 in other strains, p = 0.004), and KQE duplications were seen only in subtype B. Further studies are needed to determine whether such genotypic differences influence viral replication capacity, antiretroviral drug susceptibility, or other phenotypic properties of these strains.Keywords
This publication has 17 references indexed in Scilit:
- Infectivity and Replication Capacity of Drug-Resistant Human Immunodeficiency Virus Type 1 Variants Isolated during Primary InfectionJournal of Virology, 2003
- Molecular Characterization of 39 HIV-1 Isolates Representing Group M (Subtypes A-G) and Group O: Sequence Analysis ofgagp24,polIntegrase, andenvgp41AIDS Research and Human Retroviruses, 2003
- Changes in the Human Immunodeficiency Virus p7-p1-p6 gag Gene in Drug-Naive and Pretreated PatientsJournal of Clinical Microbiology, 2003
- Amino Acid Substitutions in Gag Protein at Non-cleavage Sites Are Indispensable for the Development of a High Multitude of HIV-1 Resistance against Protease InhibitorsJournal of Biological Chemistry, 2002
- Resistance to Nucleoside Analog Reverse Transcriptase Inhibitors Mediated by Human Immunodeficiency Virus Type 1 p6 ProteinJournal of Virology, 2001
- Impact of HIV Type 1 Protease, Reverse Transcriptase, Cleavage Site, and p6 Mutations on the Virological Response to Quadruple Therapy with Saquinavir, Ritonavir, and Two Nucleoside AnalogsAIDS Research and Human Retroviruses, 2001
- HIV-1 ReplicationSomatic Cell and Molecular Genetics, 2001
- Polymorphism of HIV Type 1 Gag p7/p1 and p1/p6 Cleavage Sites: Clinical Significance and Implications for Resistance to Protease InhibitorsAIDS Research and Human Retroviruses, 2000
- Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sitesJournal of Virology, 1997
- Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.Proceedings of the National Academy of Sciences, 1991